Atrial natriuretic peptide in normal and pre-eclamptic human pregnancy

Fetal and Maternal Medicine Review

Volumn 9, Issue 4, 1997, Pages 209-221

  Irons, D W ^a   Baylis, P H ^a   Davison, J M ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

HUMAN; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PROTEIN ANALYSIS; PROTEIN STRUCTURE; REVIEW;

EID: 0031462472     PISSN: 09655395     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0965539597000144     Document Type: Review

References (102)

1. Brown MA. Gallery ED. Volume homeostasis in normal pregnancy and pre-eclampsia: physiology and clinical implications. Ballières Clin Obstet Gynaecol 1994; 8: 287-310.
2. Gallery EDM, Delprado W, Györy AZ. Antihypertensive effect of plasma volume expansion in pregnancy-associated hypertension. Aust NZJ Med 1981; 11: 20-24.
3. Pirani BBK, Campbell DM, MacGillivray I. Plasma volume in normal first pregnancy. J Obstet Gynaecol Br Cwlth 1973; 80: 884-87.
4. Sturgiss SN, Dunlop W, Davison JM. Renal haemodynamics and tubular function in human pregnancy. In: Lindheimer MD, Davison JM eds, Baillière's Clinical Obstetrics and Gynaecology. London: Baillière Tindall, 1994; 8: 209-34.
5. Brown MA, Whitworth JA. The kidney in hypertensive pregnancies - victim and villain. Am J Kid Dis 1992; 20: 427-32.
6. Masilamani S, Castro L, Baylis C. Pregnant rats are refractory to the natriuretic actions of atrial natriuretic peptide. Am J Physiol 1994; 267: R1611-16.
7. Omer S, Mulay S, Cernacek P, Varma DR. Attenuation of renal effects of atrial natriuretic peptide during rat pregnancy. Am J Physiol 1995; 268: F416-22.
8. Steegers EA. Atrial natriuretic peptide during human pregnancy and puerperium. Fetal Medicine Review 1991; 3: 185-96.
9. Irons DW, Davison JM, Baylis PH. Evaluation of enzyme inhibitors of cystinyl aminopeptidase and application to the measurement of atrial natriuretic peptide in human pregnancy. Clinica Chimica Acta 1994; 231: 185-91.
10. Henry JP, Otto MD, Gauer OH, Reeves JL. Evidence of the atrial location of receptors influencing urine flow. Circ Res 1956; 4: 85-92.
11. De Wardener HE, Mills IH, Clapham WF, Hayter CJ. Studies on the efferent mechanism of the sodium diuresis which follows the administration of intravenous saline in the dog. Clin Sci 1961; 21: 249-58.
12. Kisch B. Electron microscopy of the atrium of the heart. I Guinea pig. Exp Med Surg 1956; 14: 99-112.
13. Jamieson JD, Palade GE. Specific granules in atrial muscle cells. J Cell Biol 1964; 23: 151-72.
14. de Bold AJ. Heart atria granularity effects of changes in water-electrolyte balance. Proc Soc Exp Biol Med 1979; 161: 508-11.
15. de Bold AJ, Borenstein HB, Verres AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981; 28: 89-94.
16. Flynn TG, de Bold ML, de Bold AJ. The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem Biophys Res Commun 1983; 117: 859-65.
17. Kangawa KY, Tawaragi Y, Oikawa S, Mizuno A, Sakuragawa Y, Fukida A et al. Identification of rat gamma atrial natriuretic polypeptide and characterization of the cDNA encoding its precursor. Nature 1984; 312: 152-55.
18. Seidah NG, Lazure C, Chrétien M, Thibault G, Garcia R, Cantin et al. Amino acid sequence of homologous rat atrial peptides: natriuretic activity of native and synthetic forms. Proc Natl Acad Sci 1984, 81: 2640-44.
19. Gutkowska J, Thibault G, Milne RW, Januszewicz P, Schiller PW, Cantin M, Genest J. Radioimmunoassay of atrial natriuretic factor (ANF) in rat atria. Pro Soc Exp Biol Med 1984; 176: 105-108.
20. Needleman P, Adams SP, Cole BR, Currie MG, Geller DM, Michener MC et al. Atriopeptins as cardiac hormones. Hypertension 1985; 7: 469-82.
21. Yang-Feng TL, Floyd-Smith G, Nemer M, Droun J, Francke U. The pronatriodilatin gene is located on the distal short arm of human chromosome 1 and on mouse chromosome 4. Am J Hum Genet 1985; 37: 1117-28.
22. Oikawa S, Imai M, Ueno A, Tanaka S, Noguchi T, Nakazato H et al. Cloning and sequence analysis of cDNA encoding a precursor of human atrial natriuretic polypeptide. Nature 1984; 309: 724-26.
23. Seidman CE, Duby AD, Choi E, Graham RM, Haver E, Homey C et al. The structure of rat preproatrial natriuretic factor as defined by a complimentary DNA clone. Science 1984; 225: 324-26.
24. Bloch KD, Scott JA, Zisfein JB, Fallon JT, Margolies MN, Seidman CE et al. Biosynthesis and secretion of proatrial natriuretic factor by cultured rat cardiocytes. Science 1985; 230: 1168-71.
25. Maki M, Takayanagi R, Misono KS, Pandey KN, Tibbetts C, Inagami T. Structure of rat atrial natriuretic factor precursor deduced from cDNA sequence. Nature 1984; 309: 722-24.
26. Misono K, Fukumi H, Grammer RT, Inagami T. Rat atrial natriuretic factor: complete amino acid sequence and disulfide linkage essential for biological activity. Biochem Biophys Res Commun 1984; 119: 524-29.
27. Almeida FA, Suzuki M, Scarborough RM, Lewick JA, Maack T. Clearance function of type C receptors of atrial natriuretic factor in rats. Am J Physiol 1989; 256: R469-75.
28. Scarborough RM, Hsu MA, Kang L-L, McEnroe GA, Schwartz K, Arfsten A et al. Structural and conformational requirements of ANP clearance receptors. In: Brenner BM, Laragh JH eds. Progress in Atrial Peptide Research, New York: Raven, 1989: 23-29.
29. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y et al. Brain natriuretic peptide (BNP) as a novel cardiac hormone in humans -evidence of an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991; 87: 1402-12.
30. Ogawa Y, Itoh H, Nakao K. Molecular biology and biochemistry of natriuretic peptide family. Clin Exp Pharmacol Physiol 1995; 22: 49-54.
31. Lee RT, Bloch KD, Pfeffer JM, Neer E, Seidman CE. Atrial natriuretic factor expression in ventricles of rats with spontaneous biventricular hypertrophy. J Clin Invest 1988, 81; 431-34.
32. Napier MA, Vandlen RL, Albers-Schonberg G, Nutt RF, Brady S, Lyle T et al. Specific membrane receptors for atrial natriuretic factor in renal and vascular tissues. Proc Natl Acad Sci 1984; 81: 5946-50.
33. Bianchi C, Gutkowska J, Thibault G, Garcia R, Genest J, Cantin M. Radioautographic localization of atrial natriuretic factor in rat tissues. Histochemistry 1985; 82: 441-50.
34. Myanth CR, Kurger L, Brecha NC, Mantayh PW. Localization of specific binding sites for atrial natriuretic factor in peripheral tissues of the guinea pig, rat and human. Hypertension 1986; 8: 712-21.
35. Martin ER, Ballermann BJ. Atrial natriuretic peptide receptors. In: Brenner BM, Stein JH, eds. Contemporary Issues in Nephrology. Atrial Natriuretic Peptide. New York: Churchill Livingstone, 1989; 21: 105-36.
36. Kingdom JCP, McQueen J, Ryan G, Connell JMC, Whittle MJ. Fetal vascular atrial natriuretic peptide receptors in human placenta: alteration in intrauterine growth retardation and preeclampsia. Am J Obstet Gynecol 1994; 170: 142-47.
37. Chinkers M, Garbes DL, Chang MS, Lowe DG, Chin H, Schulz S. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 1989; 338: 78-83.
38. Maack T, Suzuki M, Almeida FA, Nussenzveig D, Scarborough RM, McEnroe GA et al. Physiological role of silent receptors of atrial natriuretic factor. Science 1987; 238: 675-78.
39. Takayanagi R, Inagami T, Snajdar RM, Imada T, Tamura M, Misono KS. Two distinct forms of receptors for atrial natriuretic factor in bovine adrenal cortical cells. J Biol Chem 1987; 262: 12104-13.
40. Levin E. Natriuretic peptide receptor more than just a clearance receptor. Am J Physiol 1993; 264: E483-89.
41. Seidman CE, Bloch KD, Zisfein J, Smith JA, Haber E, Homcy C et al. Molecular studies of the atrial natriuretic factor gene. Hypertension 1985; 7 suppl: 131-34.
42. Gardner DG, Deschepper CF, Ganong WF, Hane S, Fiddes J, Baxter JD et al. Extra atrial expression of the gene for atrial natriuretic factor. Proc Natl Acad Sci 1986; 83: 6697-701.
43. Thibault G, Nemer M, Drouin J, Lavigne JP, Ding J, Charbonneau C et al. Ventricles as a major site of atrial natriuretic factor synthesis and release in cardiomyopathic hamsters with heart failure. Circ Res 1989; 65: 71-82.
44. Goetz KL, Wang BC, Geer PG, Leadley RJ, Reinhardt HW. Atrial stretch increases sodium excretion independently of release of a peptide. Am J Physiol 1986; 250: R946-50.
45. Fater CD, Schultz HD, Sundet WD, Mapes JS, Goetz KL. Effects of left atrial stretch in cardiac-denervated and intact conscious dogs. Am J Physiol 1982; 242: H1056-64.
46. Mancici GBJ, McGillem MJ, Bated ER, Weder AB, DeBoe SF, Grekin RJ. Hormonal response to cardiac tamponade: inhibition of atrial natriuretic factor despite elevation of atrial pressures. Circulation 1987; 76: 884-90.
47. Burrell LM, Palmer J, Charlton JA, Thomas T, Baylis PH. A new radioimmunoassay for human atrial natriuretic peptide and its physiological validation. J Immunoassay 1990; 11: 159-75.
48. Nisell H, Carlstrom K, Cizinsky S, Grunewald C, Nylund L, Randmaa I. Atrial natriuretic peptide concentrations and haemodynamic effects of acute plasma volume expansion in normal pregnancy and pre-eclampsia. Obstet Gynecol 1992; 79: 902-907.
49. Steegers EAP, Van Lakwijk HPJM, Fast JH, Godschalx AW, Jongsma HW, Eskes TK et al. Atrial natriuretic peptide and atrial size during normal pregnancy. Br J Obstet Gynaecol 1991; 98: 202-206.
50. Voto LS, Hetmanski DJ, Broughton Pipkin F. Determinants of fetal and maternal atrial natriuretic peptide concentrations at delivery in man. Br J Obstet Gynaecol 1990; 97: 1123-29.
51. Lowe SA, MacDonald GJ, Brown MA. Regulation of atrial natriuretic peptide in pregnancy: responses to posture. Am J Obstet Gynecol 1991; 165: 591-95.
52. Miyamato S, Shimokawa H, Sumioki H, Touno A, Nakano H. Circadian rhythm of plasma atrial natriuretic peptide, aldosterone and blood pressure during the third trimester in normal and preeclamptic pregnancies. Am J Obstet Gynecol 1988; 158: 393-99.
53. Nelesen RA, Dimsdale JE, Ziegler MG. Plasma atrial natriuretic peptide is unstable under most storage conditions. Circulation 1992; 86: 463-66.
54. Castro LC, Hobel CJ, Gornbein J. Plasma levels of atrial natriuretic peptide in normal and hypertensive pregnancies: a meta analysis. Am J Obstet Gynecol 1994; 171: 1642-51.
55. Thomsen JK, Fogh Andersen N, Jaszczak P. Atrial natriuretic peptide, blood volume, aldosterone and sodium excretion during twin pregnancy. Acta Obstet Gynecol Scand 1994; 73: 14-20.
56. Thomsen JK, Fogh Andersen N, Jaszczak P, Giese J. Atrial natriuretic peptide (ANP) decrease during normal pregnancy as related to hemodynamic changes and volume regulation. Acta Obstet Gynecol Scand 1993; 72: 103-10.
57. Yoshimura T. Plasma concentration of atrial natriuretic peptide and brain natriuretic peptide during normal pregnancy and postpartum. Proc Soc Gynaecol Invest 1993; 221.
58. Wong EFC, Koh LW, Huang M, Wong NLM. Plasma levels of atrial natriuretic peptide during labour and in the puerperium. Asia Oceania J Obstet Gynaecol 1990; 16: 79-83.
59. Milsom I, Hedner J, Hedner T. Plasma atrial natriuretic peptide (ANP) and maternal hemodynamic changes during normal pregnancy. Acta Obstet Gynecol Scand 1988; 67: 717-22.
60. Robson SC, Hunter S, Dunlop W. Left atrial dimension during early puerperium. Lancet 1987; 2: 111-12.
61. Walters BJN, Thompson ME, Lee A, de Swiet M. Blood pressure in the puerperium. Clin Sci 1986; 71: 589-94.
62. Stasch JP, Hirth C, Kazda S, Neuser D. The reduction of renin and aldosterone as a response to acute hypervolemia is blocked by a monoclonal antibody directed against atrial natriuretic peptides. Life Sci 1988; 42: 511-16.
63. Nadel AS, Ballerman BJ, Anderson S, Brenner BM. Interrelationships among atrial peptides, renin and blood volume in pregnant rats. Am J Physiol 1988; 254: R793-800.
64. Castro LC, Arora CP, Krakow DE, Allen RA. Atrial natriuretic peptide metabolism during pregnancy in the rat. Am J Obstet Gynecol 1994; 170: 1184-88.
65. Mukaddam-Daher S, Gutkowska J, Nuwayhid BS, Quillen EW. Metabolic clearance of atrial natriuretic factor in ovine pregnancy. Am J Physiol 1994; 267: R1413-20.
66. Olsson K., Karlberg BE, Eriksson L. Atrial natriuretic peptide in pregnant and lactating goats. Acta Endocrinologica 1989; 120: 519-25.
67. Javeshghani D, Mukaddam-Daher S, Fan L, Guan Z, Gutkowska J, Nuwayhid B et al. Control of atrial natriuretic factor by right and left atrial distention in pregnant sheep. Am J Physiol 1995; 268: R1411-17.
68. Kaufman S, Deng Y, Thai W. Influence of pregnancy on ANF release from isolated atria. Am J Physiol. 1994; 266: R1605-609.
69. Potvin W, Varma DR. Down regulation of myometrial atrial natriuretic factor receptors by progesterone and pregnancy and up regulation by oestrogen in rats. J Endocrinology 1991; 131: 259-66.
70. Mulay S, Omer S, Vaillancourt P, D'Sylva S, Singh A, Varma DR. Hormonal modulation of atrial natriuretic factor receptors and effects on adrenal glomerulosa cells of female rats. Life Sci 1994; 55: 169-76.
71. Irons DW, Baylis PH, Butler TJ, Davison JM. The effect of atrial natriuretic peptide on renal haemodynamics and sodium excretion in human pregnancy. Am J Physiol 1996; 271: F239-42.
72. Davison JM, Shiells EA, Barron WM, Robinson AG, Lindheimer MD. Changes in the metabolic clearance of vasopressin and in plasma vasopressinase throughout human pregnancy. J Clin Invest 1989; 83: 1313-18.
73. Thornton S, Davison JM, Baylis PH. Effect of human pregnancy on metabolic clearance rate of oxytocin. Am J Physiol 1990; 259: R21-24.
74. Dunlop W. Serial changes in renal haemodynamics during normal human pregnancy. Br J Obstet Gynaecol 1981; 88: 1-9.
75. Wilcox JN, Augustine A, Goeddel DV, Lowe DG. Differential regional expression of three natriuretic peptide receptor genes within primate tissues. Mol Cell Biol 1991; 11: 3454-62.
76. McQueen J, Kingdom JC, Whittle MJ, Connell JM. Characterization of atrial natriuretic peptide receptors in human fetoplacental vasculature. Am J Physiol 1993; 264: H798-804.
77. Hollister AS, Rodeheffer RJ, White FJ, Potts JR, Imada T, Inagami T. Clearance of atrial natriuretic factor by lung, liver and kidney in human subjects and the dog. J Clin Invest 1989; 83: 623-28.
78. Tang J, Webber RJ, Chang D, Chang JK, Kiang J, Wei ET. Depressor and natriuretic activities of several atrial peptides. Regul Pept 1984; 9: 53-59.
79. Woods RL. Contribution of the kidney to the metabolic clearance of atrial natriuretic peptide. Am J Physiol 1988; 255: E934-41.
80. Richards M, Espiner E, Frampton C, Ikram H, Yandle T, Sopwith M et al. Inhibition of endopeptidase EC 24.11 in humans. Renal and endocrine effects. Hypertension 1990; 16: 269-76.
81. Trapani AJ, Smits GJ, McGraw DE, Spear KL, Koepke JP, Olins GM et al. Thiorphan, an inhibitor of endopeptidase 24.11, potentiates the natriuretic activity of atrial natriuretic peptide. J Cardiovasc Pharmacol 1989; 14: 419-24.
82. Hashimoto Y, Nakao K, Hama N, Imura H, Mori S, Yamaguchi M et al. Clearance mechanisms of atrial and brain natriuretic peptides in rats. Pharmaceutical Res 1994; 11: 60-64.
83. Cogan MG. Atrial natriuretic factor can increase renal solute excretion primarily by raising glomerular filtration. Am J Physiol 1986; 250: F710-14.
84. Solomon LR, Atherton JC, Bobinski H, Hillier V, Green R. Effect of low dose infusion of atrial natriuretic peptide on renal function in man. Clin Sci 1988; 75: 403-10.
85. Weidmann P, Hasler L, Gnadinger MP, Uehlinger DE, Shaw S, Rascher W et al. Blood levels and renal effects of atrial natriuretic peptide in normal man. J Clin Invest 1986; 77: 734-42.
86. Irons DW, Davison JM, Baylis PH. The metabolic clearance of atriai natriuretic peptide in human pregnancy. Am J Obstet Gynecol 1996; 175: 449-54.
87. Eiskjaer H, Schmiegelow M, Jespersen B, Tietze IN, Jensen D, Sorensen SS et al. Renal and hormonal effects and tolerance of an ANP analogue in healthy man. Eur J Pharmacol 1991; 41: 547-54.
88. Rakugi H, Ogihara T, Nakamaru M, Saito H, Shima J, Sagakuchi K et al. Renal interaction of atrial natriuretic peptide with angiotensin II: glomerular and tubular effects. Clin Exp Pharmacol Physiol 1989; 16: 97-107.
89. Seino M, Abe K, Nushiro N, Omata K, Yoshinga K. The effects of atrial natriuretic peptide on renal hemodynamics and the renal kallikrein-kinin system. J Hypertension 1988; 6: 321-27.
90. Brown J, O'Flynn MA. Acute physiological effects of atrial natriuretic peptide in man. Kidney Int 1989; 36: 645-52.
91. Brunn NE, Skott P, Giese J. Renal and endocrine effects of physiological variations of atrial natriuretic factor in normal humans. Am J Physiol 1991 ; 260: R217-24.
92. Radin JM, McCune SA. The effect of atrial natriuretic peptide infusion on renal hemodynamics and plasma lipoproteins in puromycin aminonucleotide nephrosis in rats. Clin Exp Pharmacol Physiol 1992; 20: 245-51.
93. Lang CC, Choy AMJ, Balfour DJK, Struthers AD. Prazosin attenuates the natriuretic response to atrial natriuretic factor in man. Kidney Int 1992; 42: 433-41.
94. Irons DW, Davison JM, Baylis PH. Atrial natriuretic peptide in pre-eclampsia: metabolic clearance, sodium excretion and renal haemodynamics. Am J Physiol 1997; 42: F483-87.
95. Visser W, Marinus A, van den Dorpel MA, Derkx FHM, Wallenburg HCS, Schalekamp MADH. Atrial natriuretic peptide and haemodynamics in untreated pre-eclampsia. J Hypertens 1987; 5 (suppl): S33-35.
96. Huaibin LI, Oparil S, Meng QC, Elton TS, Chen YF. Selective down regulation of ANP-clearance receptor gene expression in lung of rats adapted to hypoxia. Am J Physiol 1995; 268: L328-35.
97. Jin H, Chen YF, Yang RH, Jackson RM, Oparil S. Atrial natriuretic peptide clearance receptor agonist lowers pulmonary pressure in hypoxic rats. J Appl Physiol 1990; 68: 2413-18.
98. Jin H, Yang RH, Thornton RM, Chen YF, Jackson RM, Oparil S. Atrial natriuretic peptide lowers pulmonary arterial pressure in hypoxia adapted rats. J Appl Physiol 1988; 65: 1729-35.
99. Richards MA, Nicholls MG, Espiner EA, Ikram H, Yandle TG, Joyce SL, Cullens MM. Effects of α-human atrial natriuretic peptide in essential hypertension. Hypertension 1985; 7: 812-17.
100. Predel HG, Schulte-Vels H, Glanzer K, Leynert HM, Kramer HJ. Atrial natriuretic peptide in patients with essential hypertension. Am J Hypertens 1991; 4: 871-79.
101. Eiskjaer H, Nielsen CB, Pederson EB. Pressure -dependent, enhanced natriuretic response to low dose, atrial natriuretic peptide infusion in essential hypertension. J Internal Medicine 1994; 236: 665-74.
102. Janssen WMT, Zeeuw D, Gjalt K, de Jong PE. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension. J Hypertension 1994; 12: 439-47.